The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats

A selective alpha-2 agonist medetomidine, a selective alpha-2 antagonist atipamezole and lidocaine were injected into the prefrontal cortex of aged rats that had been trained to perform a delayed alternation (DA) task in a T maze. Medetomidine at the dose of 0.01 microgram/microliter improved the memory task performance in four of five rats. The fifth rat improved its performance at the dose of 1.0 microgram/microliter. Atipamezole did not have any effect on the task performance. The effect of a systemic dose of medetomidine (3 micrograms/kg), which was previously shown to improve the task performance in old rats, was reversed by an intracortical injection of atipamezole. Lidocaine impaired the DA performance significantly. The results suggest that the beneficial effects of medetomidine on the working memory of old rats are mediated at least partly through the prefrontal cortex.

Medienart:

Artikel

Erscheinungsjahr:

1996

Erschienen:

1996

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Brain research bulletin - 40(1996), 2 vom: 26., Seite 117-9

Sprache:

Englisch

Beteiligte Personen:

Tanila, H [VerfasserIn]
Rämä, P [VerfasserIn]
Carlson, S [VerfasserIn]

Themen:

03N9U5JAF6
98PI200987
Adrenergic alpha-Agonists
Adrenergic alpha-Antagonists
Atipamezole
Imidazoles
Journal Article
Lidocaine
MR15E85MQM
Medetomidine

Anmerkungen:

Date Completed 23.10.1996

Date Revised 19.07.2019

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM086964348